Puruflux

Puruflux is a medical device designed for the treatment and management of gastroesophageal reflux disease (GERD). It is typically formulated as oral liquids or sachets that create a physical barrier or mechanical action to prevent the ascent of gastric contents into the esophagus. This product is part of a specialized portfolio of healthcare solutions focused on digestive wellness and symptom relief for acid reflux sufferers.

The brand originates from Italy, a country renowned for its advanced pharmaceutical and nutraceutical manufacturing capabilities. Puruflux is produced by NTC Srl, an Italian R&D-driven pharmaceutical company that focuses on developing innovative therapeutic products for various healthcare sectors. The manufacturing processes adhere to strict European medical device regulations, ensuring high standards of safety and efficacy.

Ownership of the brand remains with NTC Srl, which operates internationally through a network of distributors and local partners. As an independent Italian entity, NTC Srl oversees the entire lifecycle of the product from initial clinical research to global commercialization, emphasizing their position as a key player in the European specialty pharmaceuticals market.